And occcasionally misleading about real circuits, but then bread- boards can be misleading too, but you wouldn't admit that any of your bread-boards had lead you to the wrong conclusion, would you.
Your enthusiasm for work is an example to us all, though you probably pay yourself better than any other employer would - who else would believe your claims about the quality of the work you do (let alone think you can do)?
Your enthusiasm for not-work is a different sort of inspiration. I pay myself about what I'd make as an employee, and I'm not the highest-paid person in my company.
I have tons of things to do, like finish this stupid program I'm working on instead of hiking. I was hoping someone would volunteer to measure the c-multiplier lf rejection, to cross-check the sims and/or my own eventual testing. Right now Rob has got the AM502 amplifier I'd like to use. (I should buy another one, but they're *expensive* these days. That's another story.) That amp, and some signal averaging on a scope, should resolve 140 dB, if that's the number.
Not at this instant, but then neither do you - at this instant.
on
h
I'm not in the least enthusiastic about it. You seem to think otherwise, for the - for you - excellent reason that it suits you to think that way, and you don't have a problem about parading your unrealistic fantasies.
Really?
Obviously. I've not got the equipment, and you haven't mentioned paying for the help, which might justify getting the appropriate equipment together. There is a Pico Technology USB scope sitting on the other side of the room, but it isn't hooked up yet.
Equivalents =3D generics, proving Mr. Bowden's point.
Nope.
Yahoo around a bit for "cancer drugs" and your fave EU country. When I do I see loads of horror stories--desperate patients on old therapies, unable to get the latest (American) drugs ideal for their specific conditions. Too expensive, one assumes.
Note that of the ten "block-buster" drugs listed - more that $1B revenue per year - seven belong to European=3Dbased drug companies. The three drugs developed by US-based companies are good for twice the revenue of the seven developed by European-based companies - Atorvastatin (Lipitor) on its own matches their combined revenue. I was recently switched from Lipitor to the european-developed Simvastatin, probably because Simvastatin is now cheaper (patent expired) and equally effective, though Pfizer would like you to think otherwise
formatting link
mvastatin/
Patented drugs - which is what Mr. Bowden was talking about - aren't available as generics. If they are produced by anyone who doesn't own the patent, the producer has to pay royalties to the patent-holder. You claim to understand business and high technology and should understand this. The European pharmacutical companies make much too much money out of their patented drugs to countenance the sort of piracy that goes on in parts of the less developed world.
More likely, not cost-effective enough. Drug companies are good at tweaking drug formulations and claiming that their latest (and most expensive) recipe is what the patient really needs. Evidence-based medicine rarely confirms their claims. Patients are less inclined to wait until some touted variation has made it through clinical trials and been certified by the Cochrane collaboration.
formatting link
Desperate patients form the basis of a lot of right-wing ancedotes about European health care. Any time now you are going to tell me that Stephen Hawking would be dead by now (which he isn't) if he'd been looked after by the British National Health Service (which has looked after him ever since he was diagnosed with motor neurone disease back in 1963) as right-wing critics of "socialised medicine" have been known to do.
The British National Health Service is appreciably more careful with its money than US health insurers or the French and German equivalents, but the British Health Service is also appreciably cheaper than its French and German equivalents. It doesn't deliver the same public health statistics as the French and German systems (which do as well as the best of US healthcare, available only to the fully insured 65%) though better than the US system can manage fpr the population as a whole.
What they don't tell you is that "10 weeks average increased survival" often means some people live much longer, while others get no benefit. If you're in the 1st camp, you're a happy camper.
formatting link
[snip]
Wait, that's a change. I thought US insurers were greedy bastards withholding treatment for profit. Now they're greedy penny-pinchers and they foolishly blow megabux uselessly on hopeless patients?
ElectronDepot website is not affiliated with any of the manufacturers or service providers discussed here.
All logos and trade names are the property of their respective owners.